Study, year | Country | Study design | Methodology | Study participants | Study site | Sample size | Study period | Main focus of the study | Level of evidence |
---|---|---|---|---|---|---|---|---|---|
Tortajada-Goitia B, et al., 2020 [15] | Spain | cross-sectional study | online survey | hospital pharmacists | hospital | 185 | March 14, 2020 – May 22, 2020 | To analyze the status of the implementation and development of telepharmacy as applied to the pharmaceutical care of outpatients treated at hospital pharmacy services in Spain during the COVID-19 pandemic | 2- |
Hoti K, et al., 2020 [4] | Kosovo | cross-sectional study | online survey | community pharmacists | community pharmacy | 264 | April 1, 2020– April 30, 2020 | Community pharmacists’ perceptions of COVID-19 related preventative measures | 2- |
Hussain I, et al., 2020 [31] | Pakistan | cross-sectional study | online survey | pharmacists | academia, retail and community pharmacy, hospital, and drug inspector | 1149 | March 30, 2020–May 22, 2020 | To investigate pharmacists’ knowledge, attitudes, and practices regarding COVID-19 during the rapid rise period of the COVID-19 pandemic in Pakistan | 2- |
Abdel Jalil M, et al., 2020 [32] | Jordan | cross-sectional study | online survey | pharmacists | hospital or clinical, community pharmacy, academia and research | 449 | March 1, 2020–March 31, 2020 | To assess the possible roles of Jordanian pharmacists in minimizing the stage of community transmission | 2- |
ElGeed H, et al., 2021 [7] | Qatar | cross-sectional study | online survey | pharmacists | community pharmacy | 311 | May 28, 2020 – June 18, 2020 | To investigate the current practices, response preparedness and professional development needs of community pharmacists | 2- |
Meghana A, et al., 2021 [33] | India | cross-sectional study | online survey | pharmacists | academia, clinic and community pharmacy | 24 | Not provided | To gain rapid insights from pharmacy professionals in India regarding their roles and preparedness for the COVID-19 pandemic | 2- |
Bahlol M, et al., 2021 [5] | Egypt | cross-sectional study | in-person interview | pharmacists | community pharmacy | 1018 | April 8, 2020–April 19, 2020 | To assess community pharmacies’ preparedness for the COVID-19 pandemic | 2- |
Wang R, et al., 2021 [34] | China | retrospective, observational study | electronic health records survey | COVID-19 patients admitted to ICU | hospital (ICU) | 33 | February 1, 2020–March 18, 2020 | To share professional experiences on medication optimization and provide a feasible reference for the pharmaceutical care of critically ill patients with COVID-19 | 2- |
Sum ZZ, et al., 2021 [6] | Australia | cross-sectional study | online survey | pharmacists | community pharmacy | 137 | April 1, 2020– April 30, 2020 | To explore the current activities undertaken across various community pharmacy settings in relation to the safety of the workplace environment for staff and patients | 2- |
Zaidi STR, et al., 2021 [35] | UK | cross-sectional study | online survey | pharmacists | community pharmacy | 206 | May 4, 2020– May 30, 2020 | To survey community pharmacists to understand their protective practices, professional and general wellbeing, and the delivery of pharmacy services during the COVID19 pandemic | 2- |
Muhammad K, et al., 2021 [36] | Pakistan | cross-sectional study | online survey | pharmacists | community pharmacy | 393 | April 10, 2020– April 30, 2020 | To assess the knowledge, attitude, and practices of community pharmacists regarding COVID-19 | 2- |
Baratta F, et al., 2021 [13] | Italy | observational study, cross-sectional study | serological test, self-report questionnaire | pharmacists | community pharmacy | 286 | July 1, 2020– July 31, 2020 | To analyze the directives provided to pharmacists in 2020 regarding preventative safety measures to be adopted; to determine the number of pharmacists who came into contact with SARS-CoV-2 and relate this to the adopted preventative measures | 2- |
Yerram P, et al., 2021 [16] | USA | retrospective, observational study | electronic health records survey | patient involved with clinical pharmacy specialist | outpatient clinics | 4022 | March 1, 2020– May 31, 2020 | To present an approach to restructuring clinical pharmacy services and providing direct patient care in outpatient clinics during the pandemic | 2- |
Jovičić-Bata J, et al., 2021 [37] | Serbia | cross-sectional study | online survey | pharmacists | community pharmacy | 392 | April 1, 2020– May 31, 2020 | To present work environment changes related to COVID-19 | 2- |
Akour A, et al., 2021 [17] | Jordan | cross-sectional study | online survey | patients with chronic disease who use community pharmacies | social media platforms | 431 | May 1, 2020–August 31, 2020 | To evaluate the effect of the COVID-19 lockdown while exploring the role of community pharmacists | 2- |
Giua C, et al., 2021 [12] | Italy | cross-sectional study | online survey | pharmacists | community pharmacy | 169 | April 8, 2020– April 16, 2020 | To describe procedures and critical logistical-organizational issues encountered by Italian community pharmacists and to collect the main requests reported by patients to pharmacists | 2- |
Elsayed AA, et al., 2021 [8] | Egypt | cross-sectional study | online survey | pharmacists | community pharmacy | 413 | August 1, 2020–August 30, 2020 | To describe antibiotic misuse and its contributing factors; to measure pharmacists’ application of infection preventive practices during the pandemic | 2- |
Nguyen HTT, et al., 2021 [38] | Vietnam | cross-sectional study | mailing survey | community pharmacists | community pharmacy | 1023 | June 1, 2020– August 31, 2020 | To survey the knowledge, attitudes, and practices of pharmacists regarding the COVID-19 pandemic | 2- |
Novak H, et al., 2021 [10] | Croatia and Serbia | cross-sectional study | online survey | community pharmacists | community pharmacy, social media platforms | 574 (Croatia: 328, Serbia: 246) | June 1,2020–August 9,2020 (Croatia), July 1,2020–September 8, 2020 (Serbia) | To explore and compare the community pharmacists’ roles, practices, implemented safety measures, and psychological toll during the COVID-19 pandemic | 2- |
Wang D, et al., 2021 [19] | China | retrospective study | electronic health records survey | patients treated with pharmacotherapeutic intervention by a clinical pharmacist | hospital | 349 | February 5, 2020–March 10, 2020 | To evaluate the usefulness of clinical prevention and control measures of clinical pharmacists | 2- |
Kambayashi D, et al., 2021 [3] | Japan | cross-sectional study | online survey | pharmacists | community pharmacy | 1137 | October 1, 2020– October 31, 2020 | To conduct a nationwide survey among pharmacists to assess whether community pharmacists can contribute to reducing infections and the indirect secondary harm caused by COVID-19 | 2- |
Yılmaz ZK, et al., 2021 [11] | Turkey | cross-sectional study | online survey | pharmacists | community pharmacy | 393 | May 1, 2020–July 31, 2020 | To assess the knowledge, attitudes, and impressions of community pharmacists about COVID-19 and the factors affecting them | 2- |
Al-Daghastani T, et al., 2021 [39] | Jordan | cross-sectional study | online survey | community and hospital pharmacists | social media platforms | 311 | July 1, 2020– July 31, 2020 | To analyze the role of pharmacists during the COVID-19 pandemic; to measure pharmacists’ attitude toward COVID-19 safety measures | 2- |
Kua KP, et al., 2021 [18] | Malaysia | cross-sectional study | online survey | pharmacists | community pharmacy | 217 | May 1, 2020– July 31, 2020 | To examine community pharmacists’ views on their work environment, policies and preparedness for safe retail patronage to prevent the transmission of COVID-19 | 2- |
Kassem AB, et al., 2021 [9] | Egypt | cross-sectional study | online survey | community pharmacists | community pharmacy | 381 | April 14, 2020– June 3, 2020 | To evaluate the sources of knowledge and readiness of community pharmacists facing the COVID-19 early outbreak, to identify how far precautionary measures were applied in community pharmacies | 2- |
Elayeh E, et al., 2021 [40] | Jordan | cross-sectional study | online survey | residents | social media platforms | 1179 | March 26, 2021– April 16, 2021 | To evaluate the type of drugs and treatments used to self-medicate/self-care during the pandemic, the reasons behind their self-medication, the sources of information and the factors affecting their practices | 2- |
Okuyan B, et al., 2021 [41] | Turkey | cross-sectional study | online survey | community pharmacists | community pharmacy | 1098 | May 21, 2020– May 29, 2020 | To identify community pharmacist-led cognitive services and precautions taken related to COVID-19, perceived enablers and barriers related to pharmaceutical services and burnout level during the COVID-19 pandemic | 2- |
Mukattash TL, et al., 2022 [42] | Lebanon | cross-sectional study | online survey | home-treated COVID-19 patients | online questionnaire platform | 279 | October 2020 | To explore the experiences and views of COVID-19 patients towards pharmaceutical care services provided during their infection | 2- |
Patel J, et al., 2022 [43] | USA | cross-sectional study | telephone survey | patients who received a pharmacist-provided COVID-19 test at a large-chain community pharmacy | contacted by telephone | 622 | May 1, 2020–June 14, 2020 | To determine the local impact of community pharmacist-provided COVID-19 testing | 2- |
Alnajjar MS, et al., 2022 [44] | UAE | cross-sectional study | online survey | community and hospital pharmacists | hospital, community pharmacy | 376 | August 1, 2020–January 31, 2021 | To evaluate pharmacists’ knowledge about and practice in the global COVID-19 pandemic | 2- |